NexImmune, Inc. (NASDAQ:NEXI – Get Free Report) traded up 7% during mid-day trading on Thursday . The stock traded as high as $0.38 and last traded at $0.38. 839 shares changed hands during trading, a decline of 100% from the average session volume of 1,018,146 shares. The stock had previously closed at $0.36.
NexImmune Stock Performance
The company’s fifty day moving average is $1.22 and its 200-day moving average is $3.03. The firm has a market capitalization of $528,200.00, a P/E ratio of -0.02 and a beta of 1.82.
About NexImmune
NexImmune, Inc, a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform.
Featured Stories
- Five stocks we like better than NexImmune
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- What Makes a Stock a Good Dividend Stock?
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- About the Markup Calculator
- MarketBeat Week in Review – 9/9 – 9/13
Receive News & Ratings for NexImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexImmune and related companies with MarketBeat.com's FREE daily email newsletter.
